These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1526835

  • 1. [Tumor diseases in families of 600 breast cancer patients with special reference to familial adenocarcinomatosis and the Li-Fraumeni-/SBLA syndrome].
    Müller H, Mosimann S, Gebhardt M, Scott R, Spycher M, Weber W.
    Helv Chir Acta; 1992 May; 59(1):239-45. PubMed ID: 1526835
    [Abstract] [Full Text] [Related]

  • 2. Dominant inheritance in human cancer.
    Müller H.
    Anticancer Res; 1990 May; 10(2B):505-11. PubMed ID: 2190528
    [Abstract] [Full Text] [Related]

  • 3. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
    Achatz MI, Olivier M, Le Calvez F, Martel-Planche G, Lopes A, Rossi BM, Ashton-Prolla P, Giugliani R, Palmero EI, Vargas FR, Da Rocha JC, Vettore AL, Hainaut P.
    Cancer Lett; 2007 Jan 08; 245(1-2):96-102. PubMed ID: 16494995
    [Abstract] [Full Text] [Related]

  • 4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 Jan 08; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 5. Hereditary breast cancer syndromes in a Turkish population. Results of molecular germline analysis.
    Güran S, Ozet A, Dede M, Gille JJ, Yenen MC.
    Cancer Genet Cytogenet; 2005 Jul 15; 160(2):164-8. PubMed ID: 15993273
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Genetics and cancer of the breast].
    Sobol H, Bignon YJ, Eisinger F, Birnbaum D, Fervers B.
    Ann Chir; 1994 Jul 15; 48(4):303-8. PubMed ID: 8085754
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
    Gonzalez KD, Noltner KA, Buzin CH, Gu D, Wen-Fong CY, Nguyen VQ, Han JH, Lowstuter K, Longmate J, Sommer SS, Weitzel JN.
    J Clin Oncol; 2009 Mar 10; 27(8):1250-6. PubMed ID: 19204208
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Li-Fraumeni syndrome and the p53 gene].
    Thoresen SO.
    Tidsskr Nor Laegeforen; 1992 Mar 10; 112(7):887-9. PubMed ID: 1557756
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies.
    Pötzsch C, Voigtländer T, Lübbert M.
    J Cancer Res Clin Oncol; 2002 Aug 10; 128(8):456-60. PubMed ID: 12200603
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Li-Fraumeni syndrome].
    Frebourg T.
    Bull Cancer; 1997 Jul 10; 84(7):735-40. PubMed ID: 9339200
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Familial ovarian carcinoma: pedigree studies and preliminary results from linkage analysis.
    Sobol H, Mazoyer S, Smith SA, Lyonnet D, Bignon YJ, Narod SA, Ardoin A, Biron P, Bobin JY, Bremond A.
    Bull Cancer; 1993 Feb 10; 80(2):121-34. PubMed ID: 8173163
    [Abstract] [Full Text] [Related]

  • 18. [Molecular genetics of hereditary breast carcinoma].
    Hampl M, Chang-Claude J, Schwarz P, Saeger HD, Schackert HK.
    Zentralbl Chir; 1997 Feb 10; 122(2):67-73. PubMed ID: 9173760
    [Abstract] [Full Text] [Related]

  • 19. Follow-up study of twenty-four families with Li-Fraumeni syndrome.
    Garber JE, Goldstein AM, Kantor AF, Dreyfus MG, Fraumeni JF, Li FP.
    Cancer Res; 1991 Nov 15; 51(22):6094-7. PubMed ID: 1933872
    [Abstract] [Full Text] [Related]

  • 20. Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites.
    Rapakko K, Allinen M, Syrjäkoski K, Vahteristo P, Huusko P, Vähäkangas K, Eerola H, Kainu T, Kallioniemi OP, Nevanlinna H, Winqvist R.
    Br J Cancer; 2001 Jan 05; 84(1):116-9. PubMed ID: 11139324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.